United Therapeutics (UTHR) Total Debt (2010 - 2025)

United Therapeutics (UTHR) has 14 years of Total Debt data on file, last reported at $200.0 million in Q1 2025.

• For the quarter ending Q1 2025, Total Debt fell 66.67% year-over-year to $200.0 million; the trailing twelve-month figure through Mar 2025 stood at $200.0 million (down 66.67% YoY), and the FY2024 full-year result was $300.0 million, down 57.14% from the prior year.
• Total Debt declined to $200.0 million in Q1 2025, from $300.0 million in the prior quarter.
• In the past five years, Total Debt ranged from a high of $800.0 million in Q1 2021 to a low of $200.0 million in Q1 2025.
• A 5-year average of $676.5 million and a median of $800.0 million in 2021 frame the typical range for Total Debt.
• Across the five-year window, Total Debt changed 0.0% in 2021 and tumbled 66.67% in 2025, its largest moves.
• Tracing UTHR's Total Debt over 5 years: stood at $800.0 million in 2021, then changed by 0.0% to $800.0 million in 2022, then dropped by 12.5% to $700.0 million in 2023, then slumped by 57.14% to $300.0 million in 2024, then sank by 33.33% to $200.0 million in 2025.
• Business Quant data shows UTHR's Total Debt at $200.0 million in Q1 2025, $300.0 million in Q4 2024, and $400.0 million in Q3 2024.